Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters)

Albert Wölfler, Peter M. Abuja, Werner Linkesch, Konrad Schauenstein, Peter M. Liebmann, Vijayalaxmi, Charles R. Thomas, Russel J. Reiter, Terence S. Herman

Research output: Contribution to journalLetter

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)4127-4129
Number of pages3
JournalJournal of Clinical Oncology
Volume20
Issue number19
DOIs
StatePublished - Oct 1 2002

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Wölfler, A., Abuja, P. M., Linkesch, W., Schauenstein, K., Liebmann, P. M., Vijayalaxmi, Thomas, C. R., Reiter, R. J., & Herman, T. S. (2002). Questionable benefit of melatonin for antioxidant pharmacologic therapy [6] (multiple letters). Journal of Clinical Oncology, 20(19), 4127-4129. https://doi.org/10.1200/JCO.2002.99.158